VBL Therapeutics and NanoCarrier Co., Ltd. Sign Exclusive Agreement for VB-111 in Japan, VBL To Receive $15M Upgront And Is Entitled To Receive $100M In Development And Commercial Milestone Payments
Paul Quintaro